Distinct terminal and cell body mechanisms in the nociceptor mediate hyperalgesic priming
- PMID: 25878283
- PMCID: PMC4397607
- DOI: 10.1523/JNEUROSCI.5085-14.2015
Distinct terminal and cell body mechanisms in the nociceptor mediate hyperalgesic priming
Abstract
Hyperalgesic priming, a form of neuroplasticity in nociceptors, is a model of the transition from acute to chronic pain in the rat, which involves signaling from the site of an acute tissue insult in the vicinity of the peripheral terminal of a nociceptor to its cell body that, in turn, induces a signal that travels back to the terminal to mediate a marked prolongation of prostaglandin E2-induced hyperalgesia. In the present experiments, we studied the underlying mechanisms in the cell body and compared them to the mechanisms in the nerve terminal. Injection of a cell-permeant cAMP analog, 8-bromo cAMP, into the dorsal root ganglion induced mechanical hyperalgesia and priming with an onset more rapid than when induced at the peripheral terminal. Priming induced by intraganglion 8-bromo cAMP was prevented by an oligodeoxynucleotide antisense to mRNA for a transcription factor, cAMP response element-binding protein (CREB), and by an inhibitor of importin, which is required for activated CREB to get into the nucleus. While peripheral administration of 8-bromo cAMP also produced hyperalgesia, it did not produce priming. Conversely, interventions administered in the vicinity of the peripheral terminal of the nociceptor that induces priming-PKCε activator, NGF, and TNF-α-when injected into the ganglion produce hyperalgesia but not priming. The protein translation inhibitor cordycepin, injected at the peripheral terminal but not into the ganglion, reverses priming induced at either the ganglion or peripheral terminal of the nociceptor. These data implicate different mechanisms in the soma and terminal in the transition to chronic pain.
Keywords: dorsal root ganglion; hyperalgesic priming; mechanical hyperalgesia; nociceptor; rat.
Copyright © 2015 the authors 0270-6474/15/356107-10$15.00/0.
Figures









Similar articles
-
Hyperalgesic priming is restricted to isolectin B4-positive nociceptors.Neuroscience. 2010 Aug 11;169(1):431-5. doi: 10.1016/j.neuroscience.2010.04.082. Epub 2010 May 10. Neuroscience. 2010. PMID: 20457222 Free PMC article.
-
In Vitro Nociceptor Neuroplasticity Associated with In Vivo Opioid-Induced Hyperalgesia.J Neurosci. 2019 Sep 4;39(36):7061-7073. doi: 10.1523/JNEUROSCI.1191-19.2019. Epub 2019 Jul 12. J Neurosci. 2019. PMID: 31300521 Free PMC article.
-
Accounting for the delay in the transition from acute to chronic pain: axonal and nuclear mechanisms.J Neurosci. 2015 Jan 14;35(2):495-507. doi: 10.1523/JNEUROSCI.5147-13.2015. J Neurosci. 2015. PMID: 25589745 Free PMC article.
-
Critical role of nociceptor plasticity in chronic pain.Trends Neurosci. 2009 Dec;32(12):611-8. doi: 10.1016/j.tins.2009.07.007. Epub 2009 Sep 24. Trends Neurosci. 2009. PMID: 19781793 Free PMC article. Review.
-
The pharmacology of nociceptor priming.Handb Exp Pharmacol. 2015;227:15-37. doi: 10.1007/978-3-662-46450-2_2. Handb Exp Pharmacol. 2015. PMID: 25846612 Free PMC article. Review.
Cited by
-
SDF1-CXCR4 Signaling Contributes to the Transition from Acute to Chronic Pain State.Mol Neurobiol. 2017 May;54(4):2763-2775. doi: 10.1007/s12035-016-9875-5. Epub 2016 Mar 24. Mol Neurobiol. 2017. PMID: 27011380
-
Schwann Cell Autocrine and Paracrine Regulatory Mechanisms, Mediated by Allopregnanolone and BDNF, Modulate PKCε in Peripheral Sensory Neurons.Cells. 2020 Aug 11;9(8):1874. doi: 10.3390/cells9081874. Cells. 2020. PMID: 32796542 Free PMC article.
-
Systemic Morphine Produces Dose-dependent Nociceptor-mediated Biphasic Changes in Nociceptive Threshold and Neuroplasticity.Neuroscience. 2019 Feb 1;398:64-75. doi: 10.1016/j.neuroscience.2018.11.051. Epub 2018 Dec 7. Neuroscience. 2019. PMID: 30529265 Free PMC article.
-
Low GRK2 Underlies Hyperalgesic Priming by Glial Cell-Derived Neurotrophic Factor.Front Pharmacol. 2018 Jun 5;9:592. doi: 10.3389/fphar.2018.00592. eCollection 2018. Front Pharmacol. 2018. PMID: 29922165 Free PMC article.
-
Phosphorylated CCAAT/Enhancer Binding Protein β Contributes to Rat HIV-Related Neuropathic Pain: In Vitro and In Vivo Studies.J Neurosci. 2018 Jan 17;38(3):555-574. doi: 10.1523/JNEUROSCI.3647-16.2017. Epub 2017 Dec 1. J Neurosci. 2018. PMID: 29196315 Free PMC article.
References
-
- Ahluwalia A, Jones MK, Szabo S, Tarnawski AS. Aging impairs transcriptional regulation of vascular endothelial growth factor in human microvascular endothelial cells: implications for angiogenesis and cell survival. J Physiol Pharmacol. 2014;65:209–215. - PubMed
-
- American College of Rheumatology. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum. 2000;43:1905–1915. doi: 10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO%3B2-P. - DOI - PubMed